Browse articles from EyeWorld.org related to IOLs. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ First patient treated in Phase 2 study of investigational emulsion for glaucoma ➤ FDA issues complete response letter for dry eye drug NDA ➤ FDA meeting minutes issued for BLA submissions of ophthalmic formulation of bevacizumab ➤ Phase 1/2 trial to begin for first-in-class dry AMD therapy ➤ Company merger news ➤ ASCRS news and events
In the years since Shin Yamane, MD, PhD, presented on flanged double-needle intrascleral haptic fixation, many surgeons have adopted the technique, but it’s not without complications. Three physicians provided their thoughts on some of the more common complications as well as pearls for handling each situation.
The IC-8 Apthera IOL (Bausch + Lomb) is now available in the U.S., and several surgeons discussed how this technology fits in to their practice and for which patients.
➤ First AI foundation model in ophthalmology ➤ 24-month topline data from Phase 3 geographic atrophy therapy ➤ Positive data from Phase 1/2 trial for retinitis pigmentosa, Leber congenital amaurosis treatment ➤ FDA clearance granted for portable retinal imaging system ➤ ASCRS news and events
Precise placement and subsequent stability of a toric IOL are of the utmost importance for success in correcting astigmatism. Capsule tears can threaten both factors. So what do you do when a capsule tear occurs during cataract surgery where you planned to implant a toric IOL?
➤ First implantations for clinical trials for investigational IOLs ➤ Phase 2 clinical trial for wet AMD treatment completes enrollment ➤ Two-year results from trial showcase vision gains in wet AMD at extended aflibercept dosing intervals ➤ Acquisition update ➤ ASCRS news and events
➤ Positive Phase 3 results from trial investigating ocular pain, inflammation treatment ➤ Study evaluates use of sustained-release drug during Medicare pass-through program ➤ FDA approves treatment for geographic atrophy ➤ Dementia ‘much higher’ in patients with visual problems ➤ ASCRS news and events
➤ Update on safety review of geographic atrophy drug ➤ IND application accepted by FDA for wet AMD gene therapy ➤ Phase 2 trial planned for investigational neuropathic corneal pain treatment ➤ Interim Phase 2 data for sustained wet AMD treatment ➤ ASCRS news and events
“What better theme for the EyeWorld issue that follows the ASCRS Annual Meeting than ‘Best practices’?” said Mitchell Weikert, MD. In his introduction to the Cataract section, he shared some highlights from the 2023 ASCRS Annual Meeting and previewed the articles in the section.
“Best practices, or our continued efforts to improve the safety, quality, and consistency of eyecare, improve patients’ quality of vision,” said Karolinne Rocha, MD, PhD. She gave an overview of the articles in the Refractive Surgery section of this issue in her introduction.